These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10763690)
1. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. Helm GA; Alden TD; Beres EJ; Hudson SB; Das S; Engh JA; Pittman DD; Kerns KM; Kallmes DF J Neurosurg; 2000 Apr; 92(2 Suppl):191-6. PubMed ID: 10763690 [TBL] [Abstract][Full Text] [Related]
2. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Dumont RJ; Dayoub H; Li JZ; Dumont AS; Kallmes DF; Hankins GR; Helm GA Neurosurgery; 2002 Nov; 51(5):1239-44; discussion 1244-5. PubMed ID: 12383369 [TBL] [Abstract][Full Text] [Related]
3. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [TBL] [Abstract][Full Text] [Related]
4. The osteoinductive properties of Nell-1 in a rat spinal fusion model. Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC Spine J; 2007; 7(1):50-60. PubMed ID: 17197333 [TBL] [Abstract][Full Text] [Related]
6. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Alden TD; Pittman DD; Hankins GR; Beres EJ; Engh JA; Das S; Hudson SB; Kerns KM; Kallmes DF; Helm GA Hum Gene Ther; 1999 Sep; 10(13):2245-53. PubMed ID: 10498255 [TBL] [Abstract][Full Text] [Related]
7. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244 [TBL] [Abstract][Full Text] [Related]
8. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. Alden TD; Beres EJ; Laurent JS; Engh JA; Das S; London SD; Jane JA; Hudson SB; Helm GA J Craniofac Surg; 2000 Jan; 11(1):24-30. PubMed ID: 11314095 [TBL] [Abstract][Full Text] [Related]
9. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105 [TBL] [Abstract][Full Text] [Related]
10. The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits. Laurent JJ; Webb KM; Beres EJ; McGee K; Li J; van Rietbergen B; Helm GA J Neurosurg Spine; 2004 Jul; 1(1):90-4. PubMed ID: 15291027 [TBL] [Abstract][Full Text] [Related]
11. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Peterson B; Iglesias R; Zhang J; Wang JC; Lieberman JR Spine (Phila Pa 1976); 2005 Feb; 30(3):283-9; discussion 289-90. PubMed ID: 15682007 [TBL] [Abstract][Full Text] [Related]
12. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of bone morphogenetic proteins 2 and 7 by ex vivo gene therapy in a rat spinal fusion model. Kaito T; Johnson J; Ellerman J; Tian H; Aydogan M; Chatsrinopkun M; Ngo S; Choi C; Wang JC J Bone Joint Surg Am; 2013 Sep; 95(17):1612-9. PubMed ID: 24005203 [TBL] [Abstract][Full Text] [Related]
14. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus. Li JZ; Hankins GR; Kao C; Li H; Kammauff J; Helm GA J Gene Med; 2003 Sep; 5(9):748-56. PubMed ID: 12950065 [TBL] [Abstract][Full Text] [Related]
15. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Varady P; Li JZ; Cunningham M; Beres EJ; Das S; Engh J; Alden TD; Pittman DD; Kerns KM; Kallmes DF; Helm GA Hum Gene Ther; 2001 Apr; 12(6):697-710. PubMed ID: 11426468 [TBL] [Abstract][Full Text] [Related]
16. CT and radionuclide study of BMP-2 gene therapy-induced bone formation. Varady P; Li JZ; Alden TD; Kallmes DF; Williams MB; Helm GA Acad Radiol; 2002 Jun; 9(6):632-7. PubMed ID: 12061736 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector. Okubo Y; Bessho K; Fujimura K; Iizuka T; Miyatake SI J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S99-104. PubMed ID: 11314802 [TBL] [Abstract][Full Text] [Related]
18. De novo osteogenesis from human ligamentum flavum by adenovirus-mediated bone morphogenetic protein-2 gene transfer. Yang IH; Kim H; Kwon UH; Lee KI; Jun JA; Kim JH; Yun CO; Park SY; Lee HM; Moon SH Spine (Phila Pa 1976); 2005 Dec; 30(24):2749-54. PubMed ID: 16371898 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Cheng SL; Lou J; Wright NM; Lai CF; Avioli LV; Riew KD Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352 [TBL] [Abstract][Full Text] [Related]